Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2019-02-06
DOI
10.1080/21645515.2019.1578595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America
- (2017) Zoe Moodie et al. JOURNAL OF INFECTIOUS DISEASES
- Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
- (2017) Claire Vigne et al. Human Vaccines & Immunotherapeutics
- Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries
- (2016) T. A. Wartel et al. Asia-Pacific Journal of Public Health
- Epidemic resurgence of dengue fever in Singapore in 2013-2014: A virological and entomological perspective
- (2016) Hapuarachchige Chanditha Hapuarachchi et al. BMC INFECTIOUS DISEASES
- Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
- (2016) Lesley J. Scott DRUGS
- Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction
- (2016) Eric Plennevaux et al. VACCINE
- Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
- (2016) Sophia Gailhardou et al. PLoS Neglected Tropical Diseases
- 2013 Dengue Outbreaks in Singapore and Malaysia Caused by Different Viral Strains
- (2015) Lee-Ching Ng et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Unknown
- (2015) IMMUNOLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
- (2015) Ilaria Dorigatti et al. VACCINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials
- (2014) Vivaldo G. da Costa et al. VACCINE
- A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
- (2014) Dong Soo Kim et al. Human Vaccines & Immunotherapeutics
- Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease
- (2014) Mark K. Slifka Frontiers in Immunology
- Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
- (2013) Anke Harenberg et al. Human Vaccines & Immunotherapeutics
- Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
- (2013) Raphaël M. Zellweger et al. PLoS Pathogens
- Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination
- (2012) Laurent Coudeville et al. PLoS One
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years
- (2012) Yee Sin Leo et al. Human Vaccines & Immunotherapeutics
- Forecast of Dengue Incidence Using Temperature and Rainfall
- (2012) Yien Ling Hii et al. PLoS Neglected Tropical Diseases
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Dengue virus surveillance in Singapore reveals high viral diversity through multiple introductions and in situ evolution
- (2011) Kim-Sung Lee et al. INFECTION GENETICS AND EVOLUTION
- Clinical, epidemiological and virological features of dengue virus infections in vietnamese patients presenting to primary care facilities with acute undifferentiated fever
- (2010) Khoa T.D. Thai et al. JOURNAL OF INFECTION
- Emergence of the Asian 1 Genotype of Dengue Virus Serotype 2 in Viet Nam: In Vivo Fitness Advantage and Lineage Replacement in South-East Asia
- (2010) Vu Thi Ty Hang et al. PLoS Neglected Tropical Diseases
- Immunological serotype interactions and their effect on the epidemiological pattern of dengue
- (2009) M. Recker et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
- (2008) Robert Edelman et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started